Gavan Technologies secures US$8M to commercialize plant-based fat solution

ISRAEL – Gavan Technologies, an Israeli food-tech company, has raised US$8 million in Series A funding to advance the commercial rollout of its plant-based fat alternative, Fatrix.

Founded in 2018 and based in Israel, Gavan plans to use the funds to establish a pilot production facility in Europe by April 2025. 

The facility will produce Fatrix, a plant-based fat designed as a direct replacement for butter in food products and dairy alternatives. 

The funding will also support Gavan’s expansion into the European market, targeting bakery and dairy sectors.

The funding round was led by Israeli venture capital firm MoreVC, with participation from Lever VC, EIT Food (an EU-backed platform), and DarkBoot Group, a private equity firm that previously supported Gavan’s incubation.

Fatrix, the company’s key product, is a plant-based gel made from three components: protein isolate, vegetable oil, and water. 

Gavan’s proprietary technology binds these ingredients into a stable and flavor-neutral emulsion. 

Free from hydrogenation, Fatrix contains no trans fats, is low in saturated fats, and does not require novel food regulatory approval, making it market-ready.

The product is positioned as a healthier alternative to animal-derived fats and synthetic emulsifiers, enabling food producers to reduce fat content and eliminate additives while maintaining taste and texture.

Rony Patishi-Chillim, a partner at MoreVC, emphasized that Gavan’s solution responds to a growing need for plant-based fats capable of replicating the functional and sensory properties of traditional butter while aligning with health and sustainability trends.

Sign up HERE to receive our email newsletters with the latest news and insights from Africa and around the world, and follow us on our WhatsApp channel for updates.